Raquelle Mesholam-Gately, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 61 | 2023 | 6973 | 2.560 |
Why?
|
| Schizophrenic Psychology | 20 | 2022 | 1650 | 1.440 |
Why?
|
| Psychotic Disorders | 20 | 2024 | 3272 | 1.040 |
Why?
|
| Cognition Disorders | 17 | 2022 | 3969 | 0.750 |
Why?
|
| Verbal Learning | 4 | 2014 | 460 | 0.710 |
Why?
|
| Neuropsychological Tests | 27 | 2022 | 7123 | 0.630 |
Why?
|
| Event-Related Potentials, P300 | 5 | 2020 | 150 | 0.490 |
Why?
|
| Diffusion Tensor Imaging | 16 | 2022 | 2415 | 0.490 |
Why?
|
| Evoked Potentials, Auditory | 4 | 2019 | 530 | 0.440 |
Why?
|
| Cognition | 17 | 2023 | 7048 | 0.390 |
Why?
|
| Corpus Callosum | 5 | 2019 | 751 | 0.390 |
Why?
|
| Smell | 1 | 2014 | 259 | 0.380 |
Why?
|
| Clozapine | 1 | 2014 | 509 | 0.350 |
Why?
|
| Evoked Potentials, Visual | 3 | 2020 | 419 | 0.320 |
Why?
|
| Intelligence | 2 | 2017 | 922 | 0.320 |
Why?
|
| Memory Disorders | 2 | 2013 | 1193 | 0.300 |
Why?
|
| Social Perception | 4 | 2019 | 435 | 0.280 |
Why?
|
| Reward | 1 | 2014 | 981 | 0.270 |
Why?
|
| Lateral Ventricles | 2 | 2019 | 142 | 0.270 |
Why?
|
| Psychiatric Status Rating Scales | 14 | 2019 | 6018 | 0.260 |
Why?
|
| Memory | 3 | 2015 | 2191 | 0.230 |
Why?
|
| Brain | 17 | 2022 | 27178 | 0.230 |
Why?
|
| Anisotropy | 8 | 2022 | 1284 | 0.220 |
Why?
|
| Antipsychotic Agents | 2 | 2015 | 3078 | 0.190 |
Why?
|
| Endophenotypes | 3 | 2017 | 258 | 0.180 |
Why?
|
| Young Adult | 34 | 2020 | 59852 | 0.170 |
Why?
|
| Memory, Short-Term | 5 | 2022 | 1003 | 0.160 |
Why?
|
| Image Processing, Computer-Assisted | 11 | 2019 | 8926 | 0.150 |
Why?
|
| Emotional Intelligence | 1 | 2019 | 135 | 0.150 |
Why?
|
| Myelin Sheath | 2 | 2019 | 652 | 0.140 |
Why?
|
| Attention | 4 | 2019 | 2417 | 0.140 |
Why?
|
| Frontal Lobe | 2 | 2015 | 1409 | 0.140 |
Why?
|
| Aptitude | 1 | 2017 | 43 | 0.140 |
Why?
|
| Substance-Related Disorders | 1 | 2014 | 4417 | 0.140 |
Why?
|
| Analysis of Variance | 7 | 2016 | 6203 | 0.140 |
Why?
|
| Factor Analysis, Statistical | 5 | 2019 | 999 | 0.140 |
Why?
|
| Limbic System | 1 | 2019 | 418 | 0.140 |
Why?
|
| Cannabis | 1 | 2023 | 446 | 0.130 |
Why?
|
| Attitude | 1 | 2021 | 770 | 0.130 |
Why?
|
| Humans | 71 | 2024 | 765734 | 0.130 |
Why?
|
| Psychometrics | 8 | 2019 | 3060 | 0.130 |
Why?
|
| Auditory Cortex | 1 | 2019 | 364 | 0.120 |
Why?
|
| Parahippocampal Gyrus | 1 | 2016 | 117 | 0.120 |
Why?
|
| Electroencephalography | 6 | 2020 | 6275 | 0.120 |
Why?
|
| Delusions | 2 | 2015 | 300 | 0.120 |
Why?
|
| Adult | 40 | 2022 | 222974 | 0.120 |
Why?
|
| Gyrus Cinguli | 3 | 2019 | 1116 | 0.120 |
Why?
|
| Social Stigma | 1 | 2021 | 788 | 0.120 |
Why?
|
| Male | 49 | 2021 | 363585 | 0.120 |
Why?
|
| Fluphenazine | 1 | 2014 | 35 | 0.120 |
Why?
|
| Caudate Nucleus | 1 | 2016 | 388 | 0.120 |
Why?
|
| Brain Mapping | 8 | 2022 | 6598 | 0.110 |
Why?
|
| Fornix, Brain | 1 | 2014 | 71 | 0.110 |
Why?
|
| Female | 49 | 2021 | 395961 | 0.110 |
Why?
|
| Psychological Tests | 1 | 2016 | 643 | 0.110 |
Why?
|
| Risk | 7 | 2020 | 9592 | 0.110 |
Why?
|
| Adolescent | 24 | 2022 | 88781 | 0.110 |
Why?
|
| Nerve Fibers, Myelinated | 3 | 2014 | 952 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 13 | 2022 | 36537 | 0.100 |
Why?
|
| Family | 2 | 2021 | 3207 | 0.100 |
Why?
|
| Prefrontal Cortex | 3 | 2020 | 2224 | 0.100 |
Why?
|
| Thalamus | 1 | 2019 | 1048 | 0.100 |
Why?
|
| Haloperidol | 1 | 2014 | 393 | 0.100 |
Why?
|
| Depression | 1 | 2011 | 8230 | 0.100 |
Why?
|
| Interview, Psychological | 2 | 2014 | 811 | 0.090 |
Why?
|
| Language Disorders | 1 | 2012 | 140 | 0.090 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 506 | 0.090 |
Why?
|
| GABA Agonists | 1 | 2010 | 105 | 0.090 |
Why?
|
| Genetic Markers | 1 | 2016 | 2601 | 0.090 |
Why?
|
| Genome-Wide Association Study | 2 | 2022 | 12800 | 0.090 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 259 | 0.080 |
Why?
|
| Disease Progression | 4 | 2016 | 13614 | 0.080 |
Why?
|
| Pyridazines | 1 | 2010 | 200 | 0.080 |
Why?
|
| Executive Function | 1 | 2017 | 1391 | 0.080 |
Why?
|
| Organ Size | 3 | 2018 | 2261 | 0.080 |
Why?
|
| Nerve Degeneration | 1 | 2012 | 748 | 0.070 |
Why?
|
| Social Behavior | 4 | 2019 | 1144 | 0.070 |
Why?
|
| Parietal Lobe | 1 | 2013 | 859 | 0.070 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 2045 | 0.070 |
Why?
|
| Family Health | 1 | 2012 | 1253 | 0.070 |
Why?
|
| Neural Pathways | 4 | 2019 | 3087 | 0.070 |
Why?
|
| Genetic Loci | 1 | 2016 | 2631 | 0.070 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 5 | 2018 | 2805 | 0.070 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 1407 | 0.070 |
Why?
|
| Corpus Striatum | 1 | 2013 | 1218 | 0.070 |
Why?
|
| Cerebral Cortex | 2 | 2022 | 5768 | 0.070 |
Why?
|
| Hippocampus | 2 | 2023 | 3774 | 0.070 |
Why?
|
| Psychomotor Performance | 1 | 2014 | 1883 | 0.070 |
Why?
|
| Bipolar Disorder | 1 | 2023 | 5125 | 0.060 |
Why?
|
| Triazoles | 1 | 2010 | 897 | 0.060 |
Why?
|
| Outpatients | 3 | 2019 | 1594 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2022 | 18061 | 0.060 |
Why?
|
| Middle Aged | 16 | 2019 | 222903 | 0.060 |
Why?
|
| Reference Values | 4 | 2016 | 4909 | 0.050 |
Why?
|
| National Institute of Mental Health (U.S.) | 3 | 2008 | 107 | 0.050 |
Why?
|
| Social Adjustment | 2 | 2019 | 634 | 0.050 |
Why?
|
| Interviews as Topic | 1 | 2010 | 2740 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2022 | 16041 | 0.050 |
Why?
|
| Early Diagnosis | 2 | 2019 | 1185 | 0.050 |
Why?
|
| Acute Disease | 3 | 2018 | 7232 | 0.050 |
Why?
|
| Longitudinal Studies | 4 | 2020 | 14745 | 0.040 |
Why?
|
| Clinical Trials as Topic | 4 | 2012 | 8038 | 0.040 |
Why?
|
| Case-Control Studies | 5 | 2016 | 22224 | 0.040 |
Why?
|
| Mental Recall | 2 | 2014 | 1217 | 0.040 |
Why?
|
| Statistics as Topic | 2 | 2016 | 2349 | 0.040 |
Why?
|
| Emotions | 2 | 2020 | 2764 | 0.040 |
Why?
|
| Age of Onset | 2 | 2015 | 3339 | 0.040 |
Why?
|
| Theory of Mind | 1 | 2019 | 95 | 0.030 |
Why?
|
| Cross-Sectional Studies | 4 | 2023 | 26284 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2018 | 6319 | 0.030 |
Why?
|
| Functional Laterality | 2 | 2013 | 2243 | 0.030 |
Why?
|
| Demography | 1 | 2021 | 1641 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 2 | 2008 | 1601 | 0.030 |
Why?
|
| Acoustic Stimulation | 1 | 2019 | 1255 | 0.030 |
Why?
|
| Time Factors | 3 | 2014 | 40066 | 0.030 |
Why?
|
| Child | 5 | 2023 | 80499 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 59459 | 0.030 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 39180 | 0.030 |
Why?
|
| Water | 1 | 2020 | 1418 | 0.030 |
Why?
|
| Reproducibility of Results | 4 | 2019 | 20120 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2018 | 1639 | 0.030 |
Why?
|
| Treatment Outcome | 5 | 2022 | 65180 | 0.030 |
Why?
|
| Advisory Committees | 2 | 2008 | 796 | 0.030 |
Why?
|
| Multifactorial Inheritance | 1 | 2022 | 1425 | 0.030 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2013 | 108 | 0.030 |
Why?
|
| Drug Design | 2 | 2008 | 1042 | 0.030 |
Why?
|
| Genotype | 2 | 2017 | 13024 | 0.030 |
Why?
|
| Hallucinations | 1 | 2015 | 373 | 0.020 |
Why?
|
| Psychotropic Drugs | 2 | 2008 | 880 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2019 | 1456 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 2845 | 0.020 |
Why?
|
| Massachusetts | 1 | 2024 | 8876 | 0.020 |
Why?
|
| Alleles | 1 | 2022 | 6893 | 0.020 |
Why?
|
| Aged | 5 | 2017 | 171050 | 0.020 |
Why?
|
| California | 1 | 2014 | 1434 | 0.020 |
Why?
|
| Normal Distribution | 1 | 2011 | 267 | 0.020 |
Why?
|
| Software | 2 | 2016 | 4459 | 0.020 |
Why?
|
| Speech Perception | 1 | 2014 | 512 | 0.020 |
Why?
|
| Learning | 1 | 2019 | 1755 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2017 | 41631 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2022 | 3584 | 0.020 |
Why?
|
| Diffusion | 1 | 2011 | 808 | 0.020 |
Why?
|
| Consensus | 2 | 2008 | 3200 | 0.020 |
Why?
|
| Affect | 1 | 2015 | 1498 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2014 | 9351 | 0.020 |
Why?
|
| Models, Psychological | 1 | 2011 | 824 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2013 | 1993 | 0.020 |
Why?
|
| Reaction Time | 1 | 2013 | 2086 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 15390 | 0.020 |
Why?
|
| Receptors, GABA-A | 1 | 2010 | 623 | 0.020 |
Why?
|
| United States | 5 | 2015 | 72898 | 0.020 |
Why?
|
| Expert Testimony | 1 | 2008 | 266 | 0.020 |
Why?
|
| Genomics | 1 | 2022 | 5924 | 0.020 |
Why?
|
| Age Factors | 2 | 2016 | 18375 | 0.020 |
Why?
|
| Probability | 1 | 2011 | 2473 | 0.020 |
Why?
|
| Syndrome | 1 | 2012 | 3268 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2018 | 8732 | 0.010 |
Why?
|
| Oxygen | 1 | 2016 | 4242 | 0.010 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2010 | 1987 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 7835 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2016 | 3359 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2018 | 81457 | 0.010 |
Why?
|
| Self Report | 1 | 2014 | 3772 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 15883 | 0.010 |
Why?
|
| Quality of Life | 1 | 2022 | 13462 | 0.010 |
Why?
|
| Educational Status | 1 | 2008 | 2513 | 0.010 |
Why?
|
| United States Food and Drug Administration | 1 | 2008 | 1672 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 14637 | 0.010 |
Why?
|
| Aging | 1 | 2018 | 8730 | 0.010 |
Why?
|
| Data Collection | 1 | 2008 | 3318 | 0.010 |
Why?
|
| Risk Factors | 2 | 2016 | 74831 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2019 | 42468 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2014 | 5368 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2010 | 12433 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2011 | 5088 | 0.010 |
Why?
|
| Patient Selection | 1 | 2008 | 4254 | 0.010 |
Why?
|
| Sex Factors | 1 | 2008 | 10605 | 0.010 |
Why?
|
| Algorithms | 1 | 2011 | 14061 | 0.010 |
Why?
|